Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Tourmaline Bio, Inc. - Common Stock (NQ:TRML)

47.98 UNCHANGED
Last Price Updated: 4:00 PM EDT, Oct 27, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Headline News about Tourmaline Bio, Inc. - Common Stock

< Previous 1 2 Next >
News headline image
This New Mountain Finance Analyst Turns Bearish; Here Are Top 3 Downgrades For Monday ↗
 
Via Benzinga
News headline image
Unusual volume stocks in Thursday's session ↗
Let's have a look at the stocks with an unusual volume in today's session. 
Via Chartmill
News headline image
Wall Street Cheers Nebius-Microsoft Megadeal While Apple Misses the Mark ↗
U.S. markets closed higher on Tuesday, buoyed by fresh labor data signaling a cooling job market—potentially paving the way for Fed rate cuts. Nebius soared nearly 50% on a multibillion-dollar AI-cloud... 
Via Chartmill
Topics Economy
News headline image
Let's take a look at the stocks that are in motion in today's session. ↗
Looking for insights into the US markets one hour before the close of the markets on Tuesday? Delve into the top gainers and losers of today's session and gain valuable market intelligence. 
Via Chartmill
Tourmaline Bio Stock Just Rocketed 58% Pre-Market – Here’s What Happened ↗
Via Stocktwits
News headline image
Dow Surges Over 100 Points; Korn Ferry Earnings Top Views ↗
 
Via Benzinga
Topics Stocks
News headline image
12 Health Care Stocks Moving In Tuesday's Intraday Session ↗
 
Via Benzinga
News headline image
Tourmaline Bio, QMMM Holdings, Teck Resources And Other Big Stocks Moving Higher On Tuesday ↗
 
Via Benzinga
News headline image
Why Novartis' $1.4 Billion Takeover Of Tourmaline Bio Just 'Makes Sense' ↗
Novartis agreed to buy a cardiovascular-focused biotech company 
Via Investor's Business Daily
News headline image
Novartis Snaps Up Cardio-Focused Tourmaline Bio For $1.4 Billion ↗
Tourmaline Bio shares skyrocketed Tuesday after Novartis agreed to buy the cardiovascular-focused biotech company. 
Via Investor's Business Daily
News headline image
Novartis To Expand Heart Drug Portfolio With $1.4 Billion Tourmaline Bio Acquisition ↗
Novartis agreed to acquire Tourmaline Bio for $1.4 billion as pacibekitug shows strong trial results for inflammation and cardiovascular risk reduction. 
Via Benzinga
News headline image
12 Health Care Stocks Moving In Tuesday's Pre-Market Session ↗
 
Via Benzinga
News headline image
Why Nebius Group Shares Are Trading Higher By Around 50%; Here Are 20 Stocks Moving Premarket ↗
 
Via Benzinga
News headline image
Tourmaline Bio Reports Loss as R&D Rises ↗
Via The Motley Fool
News headline image
12 Health Care Stocks Moving In Friday's After-Market Session ↗
 
Via Benzinga
News headline image
Gold Gains Over 1%; Amer Sports Posts Upbeat Earnings ↗
 
Via Benzinga
News headline image
Let's uncover which stocks are experiencing notable gaps during today's session. ↗
There are notable gap-ups and gap-downs in today's session. Let's take a look at which stocks are gapping on Tuesday. 
Via Chartmill
News headline image
Trip.com Posts Weak Earnings, Joins Vipshop, Viking Holdings And Other Big Stocks Moving Lower In Tuesday's Pre-Market Session ↗
 
Via Benzinga
News headline image
What's going on in today's pre-market session ↗
Let's have a look at what is happening on the US markets before the opening bell on Thursday. Below you can find the top gainers and losers in today's pre-market session. 
Via Chartmill
News headline image
12 Health Care Stocks Moving In Thursday's Pre-Market Session ↗
 
Via Benzinga
News headline image
This Tourmaline Bio Analyst Begins Coverage On A Bullish Note; Here Are Top 3 Initiations For Thursday ↗
 
Via Benzinga
News headline image
This Smithfield Foods Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Monday ↗
 
Via Benzinga
News headline image
TRML Stock Earnings: Tourmaline Bio Beats EPS for Q2 2024 ↗
TRML stock results show that Tourmaline Bio beat analyst estimates for earnings per share the second quarter of 2024. 
Via InvestorPlace
News headline image
TRML Stock Earnings: Tourmaline Bio Beats EPS for Q1 2024 ↗
TRML stock results show that Tourmaline Bio beat analyst estimates for earnings per share the first quarter of 2024. 
Via InvestorPlace
News headline image
12 Health Care Stocks Moving In Thursday's Intraday Session ↗
 
Via Benzinga
News headline image
Dow Jumps 200 Points; US Weekly Jobless Claims Fall ↗
U.S. stocks traded higher this morning, with the Dow Jones index gaining around 200 points on Thursday. Following the market opening Thursday, the Dow traded up 0.52% to 39,718.37 while the NASDAQ rose... 
Via Benzinga
Topics Stocks
News headline image
Why FactSet Research Shares Are Trading Lower By Around 5%? Here Are Other Stocks Moving In Thursday's Mid-Day Session ↗
Shares of FactSet Research Systems Inc. (NYSE: FDS) fell sharply during Thursday’s session after the company reported worse-than-expected second-quarter revenue and issued FY24 guidance. 
Via Benzinga
News headline image
Argenx, Immunovant Soar — As Tourmaline Plummets — On A Rival's Lackluster Test Results ↗
Investors saw Chugai's experimental drug as a potential rival to Argenx's approved medicine, Vyvgart. 
Via Investor's Business Daily
News headline image
12 Health Care Stocks Moving In Thursday's Pre-Market Session ↗
 
Via Benzinga
News headline image
Five Below Posts Q4 Results, Joins LexinFintech And Other Big Stocks Moving Lower In Thursday's Pre-Market Session ↗
U.S. stock futures were higher this morning, with the Dow futures gaining by around 100 points on Thursday. 
Via Benzinga
Topics Stocks
< Previous 1 2 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.